Sugi Predict
/ Targets
/ USP21
Top predicted compounds (top 20 by supporting neighbours, then confidence)
Clinical trials — most relevant to USP21 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
| Multicenter Vitamin E Trial in Aging Persons With Down Syndrome |
PHASE3 | COMPLETED |
| To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected Adults |
PHASE3 | WITHDRAWN |
| Phase III Study of UBT251 Injection in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Diet and Exercise Alone(UNIGUIDE-1) |
PHASE3 | NOT_YET_RECRUITING |
| A Study to Evaluate the Safety, Immunogenicity, and Efficacy of UB-612 COVID-19 Vaccine |
PHASE2/PHASE3 | WITHDRAWN |
| A Trial of Anti-CD4 Antibody UB-421 in Combination With Optimized Background Antiretroviral Therapy in Patients With Multi-Drug Resistant HIV-1 Infection |
PHASE2 | WITHDRAWN |
| A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome |
PHASE1/PHASE2 | ACTIVE_NOT_RECRUITING |
| Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma |
PHASE2 | WITHDRAWN |
| the Study to Evaluate the Safety of UB-421 in Combination With Antiretroviral Therapy (ART) and the Efficacy in Reduction of HIV Viral Load and Proviral DNA as Compared to ART Alone in ART-experienced Viremic HIV-1 Patients |
PHASE2 | WITHDRAWN |
| Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma |
PHASE2 | SUSPENDED |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-313 in Healthy Participants |
PHASE1 | COMPLETED |
| PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19 |
PHASE1 | COMPLETED |
| A Study to Evaluate the Ability of UB-612 COVID-19 Vaccine to Boost Immunity of Heterologous COVID-19 Vaccines. |
PHASE1 | WITHDRAWN |
| Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients |
PHASE1 | COMPLETED |
| Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis |
nan | UNKNOWN |
| Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
nan | RECRUITING |
| Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome |
nan | COMPLETED |
| The Danish TURNER Cryopreservation Study |
nan | RECRUITING |
| Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 |
nan | RECRUITING |
| Relationship Between Nutritional State and Respiratory Muscle Weakness in Adult Patients With Bronchietasis |
nan | UNKNOWN |
| A Natural History Study of Angelman Syndrome |
nan | RECRUITING |
| New Signaling Pathway Targeting Systemic Lupus Erythematosus |
nan | UNKNOWN |
| Low Dose Melphalan and Bortezomib for AML and High-Risk MDS |
nan | COMPLETED |
| Effect of Dietary Nitrate on Immobilization-induced Changes in Skeletal Muscle in Young Healthy Men |
nan | RECRUITING |
| Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2 |
nan | UNKNOWN |
| Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma |
nan | COMPLETED |
| Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome |
nan | COMPLETED |
| NLRP3 Inflammasome and Physical Therapy in ICU-Acquired Weakness |
nan | RECRUITING |
| Amplification of Zinc Finger Protein 217 Gene in Multiple Myeloma |
nan | UNKNOWN |
| Genetic Variation in TRAF3IP2 (rs13190932) |
nan | RECRUITING |
| Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome |
nan | RECRUITING |
Related proteins — ESM-2 sequence neighbours (a USP21 binder may also engage these)